Specifically, Novo Nordisk claims the telehealth platform infringed on the patent for semaglutide, the active ingredient found in both the pill and injectable versions of Wegovy, as well as its Ozempic diabetes treatment
Instead of seeing numbers, we see peoplewhole human beings with stories, challenges, and the potential to thrive
Can glutathione-S-transferases function as intracellular heme carriers
[2] [11] As of 2026, retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and it remains an experimental compound available only within authorised clinical trial settings
GLP-1s and Your Stomach: The Challenge The peptide nature of this hormone is why developing effective oral versions of GLP-1 medications has been so challenging, says Dr